PT  - JOURNAL ARTICLE
AU  - van Moorsel, Coline H.M.
AU  - van der Vis, Joanne J.
AU  - Benschop, Claudia
AU  - Ruven, Henk J.T.
AU  - Quanjel, Marian
AU  - Grutters, Jan C.
TI  - THE <em>MUC5B</em> PROMOTOR POLYMORPHISM ASSOCIATES WITH SEVERE COVID-19
AID  - 10.1101/2020.05.12.20099333
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.12.20099333
4099  - http://medrxiv.org/content/early/2020/05/16/2020.05.12.20099333.short
4100  - http://medrxiv.org/content/early/2020/05/16/2020.05.12.20099333.full
AB  - Background Diversity in response to exposition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is common and may be related to the innate immune response. The mucin MUC5B is an important component of the innate immune response and expression levels are associated with the MUC5B promoter polymorphism, rs35705950. The high expressing T-allele of rs35705950 is an accepted risk allele for a non-infectious aging lung disease called idiopathic pulmonary fibrosis (IPF). However, given the theory of trade-offs in aging lung disease and the importance of high expression for an adequate immune response, we hypothesize that the T-allele is protective against severe coronavirus disease 2019 (COVID-19).Methods We collected demographics, radiology, survival data and MUC5B rs35705950 allele status for 108 patients requiring hospitalisation for COVID-19 at St Antonius Hospital in The Netherlands. For comparison of allele frequencies and allele carriership with a white control cohort, the patient cohort was divided in a white (n=83) and non-white cohort.Results The patients had a median age of 66 years and consisted predominantly of males (74%) and 23 patients (21 %) died. The T-allele frequencies of rs35705950 in white patients was 0.04 which was significantly lower than the T-allele frequency of 0.10 in white controls (p= 0.02). Moreover, comparison of the number of carriers and non-carriers of the T allele showed that only 8.4% of patients carried the T-allele versus 18% of controls (p=0.029; OR= 0.41, CI=0.19-0.94).Conclusions The MUC5B rs35705950 promoter polymorphism associates with COVID-19. The risk allele (T) for IPF is protective against the development of severe COVID-19 disease. This is a further example of a trade-off between optimal expression levels in the respiratory system which associates with aging diseases. However, these results require further investigation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: ZonMW TopZorg St Antonius Care grant nr 842002001; ZonMW Topspecialistische Zorg en Onderzoek grant nr 10070012010004; Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose COVID-19 grantAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be requested from the corresponding author